Astrazeneca plc Profit Margin

The latest profit margin for AZN is 17.02% as of June 2026. That compares with 14.81% in the prior-year period — up 14.9% year over year. That is above the Healthcare sector average of 10.58%. Investors often review this figure alongside Astrazeneca plc's historical trend and sector peers before judging valuation or financial health.

Over the past year, AZN's profit margin moved from 14.81% to 17.02% — a 14.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Astrazeneca plc's valuation or profitability profile.

Against Healthcare companies, AZN currently prints 17.02% for profit margin, while the sector average sits near 10.58%. That is roughly 60.9% above the sector mean. Large gaps often invite a closer look at Astrazeneca plc's growth, margins, and balance sheet.

Profit Margin shows how effectively Astrazeneca plc converts resources into returns. At 17.02%, AZN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 14.81% in the prior-year period — up 14.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting AZN's profit margin (17.02%), review year-over-year change from 14.81%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.